Scott Schoenhaus
Stock Analyst at Keybanc
(1.97)
# 2,782
Out of 4,814 analysts
102
Total ratings
34.83%
Success rate
-9.26%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $25.21 | +26.93% | 5 | Apr 16, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $32 → $40 | $32.66 | +22.49% | 3 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $23.94 | +16.96% | 7 | Apr 16, 2025 | |
| ODD Oddity Tech | Maintains: Overweight | $52 → $50 | $41.87 | +19.42% | 3 | Apr 16, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $100 | $84.52 | +18.32% | 5 | Apr 16, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $7 → $5 | $3.85 | +29.87% | 6 | Apr 16, 2025 | |
| DOCS Doximity | Maintains: Overweight | $83 → $70 | $53.20 | +31.58% | 3 | Apr 16, 2025 | |
| CERT Certara | Maintains: Overweight | $15 → $18 | $14.15 | +27.21% | 4 | Apr 16, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $4 → $5 | $2.42 | +107.04% | 5 | Apr 16, 2025 | |
| ABSI Absci | Maintains: Overweight | $5 → $9 | $3.10 | +190.32% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $220.66 | +15.56% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $5.50 | +81.82% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $7 | $5.10 | +37.39% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $4.48 | +34.08% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.67 | +68.54% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $5.00 | +120.22% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.44 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $30.27 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $6.83 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $143.91 | +73.72% | 2 | Apr 16, 2021 |
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $25.21
Upside: +26.93%
Simulations Plus
Apr 16, 2025
Maintains: Overweight
Price Target: $32 → $40
Current: $32.66
Upside: +22.49%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $23.94
Upside: +16.96%
Oddity Tech
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $41.87
Upside: +19.42%
HealthEquity
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $84.52
Upside: +18.32%
Health Catalyst
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.85
Upside: +29.87%
Doximity
Apr 16, 2025
Maintains: Overweight
Price Target: $83 → $70
Current: $53.20
Upside: +31.58%
Certara
Apr 16, 2025
Maintains: Overweight
Price Target: $15 → $18
Current: $14.15
Upside: +27.21%
AbCellera Biologics
Apr 16, 2025
Maintains: Overweight
Price Target: $4 → $5
Current: $2.42
Upside: +107.04%
Absci
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $3.10
Upside: +190.32%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $220.66
Upside: +15.56%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $5.50
Upside: +81.82%
Jan 8, 2025
Maintains: Overweight
Price Target: $10 → $7
Current: $5.10
Upside: +37.39%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $4.48
Upside: +34.08%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.67
Upside: +68.54%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $5.00
Upside: +120.22%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $21.44
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $30.27
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $6.83
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $143.91
Upside: +73.72%